These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 18346207

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
    Vega IE, Cui L, Propst JA, Hutton ML, Lee G, Yen SH.
    Brain Res Mol Brain Res; 2005 Aug 18; 138(2):135-44. PubMed ID: 15913839
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amphiphysin-1 protein level changes associated with tau-mediated neurodegeneration.
    De Jesús-Cortés HJ, Nogueras-Ortiz CJ, Gearing M, Arnold SE, Vega IE.
    Neuroreport; 2012 Nov 14; 23(16):942-6. PubMed ID: 22975846
    [Abstract] [Full Text] [Related]

  • 5. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
    Sahara N, Vega IE, Ishizawa T, Lewis J, McGowan E, Hutton M, Dickson D, Yen SH.
    J Neurochem; 2004 Aug 14; 90(4):829-38. PubMed ID: 15287888
    [Abstract] [Full Text] [Related]

  • 6. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
    Vega IE, Umstead A, Wygant CM, Beck JS, Counts SE.
    Curr Alzheimer Res; 2018 Aug 14; 15(12):1086-1095. PubMed ID: 30101710
    [Abstract] [Full Text] [Related]

  • 7. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L, Egebjerg J, Barkholt P, Volbracht C.
    Brain Res; 2017 Jun 15; 1665():22-35. PubMed ID: 28411086
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H, Grigoriadis N, Eldar-Levy H, Avital A, Rozenstein L, Touloumi O, Behar L, Ben-Hur T, Avraham Y, Berry E, Segal M, Ginzburg I, Abramsky O.
    Exp Neurol; 2008 Jul 15; 212(1):71-84. PubMed ID: 18490011
    [Abstract] [Full Text] [Related]

  • 10. Increased neuronal activity in motor cortex reveals prominent calcium dyshomeostasis in tauopathy mice.
    Wu Q, Bai Y, Li W, Congdon EE, Liu W, Lin Y, Ji C, Gan WB, Sigurdsson EM.
    Neurobiol Dis; 2021 Jan 15; 147():105165. PubMed ID: 33166699
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
    Zhang B, Higuchi M, Yoshiyama Y, Ishihara T, Forman MS, Martinez D, Joyce S, Trojanowski JQ, Lee VM.
    J Neurosci; 2004 May 12; 24(19):4657-67. PubMed ID: 15140937
    [Abstract] [Full Text] [Related]

  • 13. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
    Matsumoto G, Matsumoto K, Kimura T, Suhara T, Higuchi M, Sahara N, Mori N.
    Int J Mol Sci; 2018 May 17; 19(5):. PubMed ID: 29772786
    [Abstract] [Full Text] [Related]

  • 14. Isolation and Detection of Pathological Tau Species in a Tauopathy Mouse Model.
    Singh AK, Selvarasu K, Durairajan SSK.
    Methods Mol Biol; 2024 May 17; 2761():317-328. PubMed ID: 38427247
    [Abstract] [Full Text] [Related]

  • 15. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C, Borghgraef P, Matarazzo V, Gielis L, Lajard AM, Voituron N, Gestreau C, Dutschmann M, Van Leuven F, Hilaire G.
    Respir Physiol Neurobiol; 2011 Sep 15; 178(2):290-303. PubMed ID: 21763469
    [Abstract] [Full Text] [Related]

  • 16. The use of mouse models to study cell-to-cell transmission of pathological tau.
    Narasimhan S, Lee VMY.
    Methods Cell Biol; 2017 Sep 15; 141():287-305. PubMed ID: 28882308
    [Abstract] [Full Text] [Related]

  • 17. GSPE interferes with tau aggregation in vivo: implication for treating tauopathy.
    Santa-Maria I, Diaz-Ruiz C, Ksiezak-Reding H, Chen A, Ho L, Wang J, Pasinetti GM.
    Neurobiol Aging; 2012 Sep 15; 33(9):2072-81. PubMed ID: 22054871
    [Abstract] [Full Text] [Related]

  • 18. Tau exhibits unique seeding properties in globular glial tauopathy.
    Chung DC, Carlomagno Y, Cook CN, Jansen-West K, Daughrity L, Lewis-Tuffin LJ, Castanedes-Casey M, DeTure M, Dickson DW, Petrucelli L.
    Acta Neuropathol Commun; 2019 Mar 07; 7(1):36. PubMed ID: 30845985
    [Abstract] [Full Text] [Related]

  • 19. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.
    Mewes A, Franke H, Singer D.
    PLoS One; 2012 Mar 07; 7(9):e45017. PubMed ID: 22984603
    [Abstract] [Full Text] [Related]

  • 20. Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice.
    Rao MV, McBrayer MK, Campbell J, Kumar A, Hashim A, Sershen H, Stavrides PH, Ohno M, Hutton M, Nixon RA.
    J Neurosci; 2014 Jul 09; 34(28):9222-34. PubMed ID: 25009256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.